ReviewComputational and structural biotechnology journal2025
Integrate & balance aspects for safe and sustainable innovation: Needs analysis on SSbD categories and product development stage requirements to cover the entire life cycle.
Review in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Perspectives on Eco-Friendly Food Packaging: Challenges, Solutions, and Trends.Foods (Basel, Switzerland) · 2025Review
- Going digital to boost safe and sustainable materials innovation markets. The digital safe-and-sustainability-by-design innovation approach of the PINK project.Computational and structural biotechnology journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current EU Strategies aim to rapidly advance the research, development and deployment of innovative advanced materials and chemicals to make Europe the first digitally enabled circular, climate-neutral and sustainable economy. To achieve this, an underlying adaptation of the research and innovation (R&I) process to the Safety-and-Sustainability-by-Design (SSbD) framework has been proposed. This perspective article provides an overview of already existing approaches providing guidance for implementing SSbD-like procedures in R&I in several different industrial sectors to ultimately replace substances of concern (SoC). Starting from the ECHA's Assessment of Alternatives (AoA) approach we put emphasis on the scoping phase during which the requirements for replacement will be identified. The limitations for the changes possible and trade-offs acceptable for the company need to be defined, in agreement with relevant stakeholders to be further involved in AoA scoping (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.